ENTITY
Novartis
Novartis
PulseAugur coverage of Novartis — every cluster mentioning Novartis across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Anthropic adds Novartis CEO Vas Narasimhan to Board of Directors
Anthropic's Long-Term Benefit Trust has appointed Vas Narasimhan, CEO of Novartis, to its Board of Directors. Narasimhan's extensive experience in developing and approving new medicines in a highly regulated industry is…
-
Google DeepMind spinoff Isomorphic Labs raises $2.1B for AI drug trials
Isomorphic Labs, an AI-driven drug discovery company spun out of Google DeepMind, has secured over $2 billion in a Series B funding round. The substantial investment, led by Thrive Capital, will be used to expand its pr…